Assessing the Clinical Effectiveness of Serum Biomarkers in the Diagnosis of Metastatic Uveal Melanoma
Observational Model: Cohort, Time Perspective: Prospective
Significant increase in biomarker level that could be linked with detection of metastases by imaging
Serum will be taken on every clinic visit from the day of diagnosis and on. Change in biomarker level will be assessed from one visit to the previous one, and correlated with imaging information on detection of metastases.
up to 12 months before diagnosis of metastases
Shahar Frenkel, MD, PhD
Hadassah Medical Organization
Israel: Ministry of Health